Contact us
Cat Health Company bags funding for nine lives extension
Startup pet longevity company focused on cats closes seed round funded by Ani.VC, Early Game Ventures and pharma angels
A couple of months ago, we reported on the launch of Ani.VC, an independent early-stage venture fund that plans to invest $35 million in companies across the United States, Europe and Asia.
Today, The Cat Health Company announced (let the cat out of the bag?) that Ani.VC is one of the participants in its pre-seed round, along with Early Game Ventures and various pharma angels.
Having closed its pre-seed round, TCHC is planning to use the funding to build up its startup, which focuses on identifying and developing new therapeutics for age-related diseases in felines, deploying both computational and laboratory approaches.
Longevity.Technology: As people become more invested in extending their own health and longevity, they are also placing greater emphasis on doing the same for their pets, particularly cats. Cat owners are increasingly focused on boosting their feline companions’ well-being, aiming to extend both their health and lifespan. Advances in human longevity, such as early diagnostics, AI-powered disease detection, and innovative treatments for challenging conditions, are starting to influence cat health care, and cat longevity looks set to be big business; pet spending in the US alone is predicted to grow to $195.6 billion by 2030, and represents one of the largest consumer spending categories, with more than 66% of households in the US owning pets, including 46.5 million households in the US that own a cat [1].
According to data prepared for Longevity.Technology by digital marketing agency Antlerzz, there has been a 121% increase in online interest in cat longevity in the US over the last ten years; worldwide, there has been a similar trend, mirroring the growing interest in dog longevity.
“We support innovative, passionate entrepreneurs whose startups are improving the lives of pets, including through new treatments and longevity-oriented care,” said Garri Zmudze, co-founder of Ani.VC. “The Cat Health Company is one of those companies. Their work developing novel drugs for feline age-related diseases is poised to give cats and their owners many more quality years together.”
Today, The Cat Health Company announced (let the cat out of the bag?) that Ani.VC is one of the participants in its pre-seed round, along with Early Game Ventures and various pharma angels.
Having closed its pre-seed round, TCHC is planning to use the funding to build up its startup, which focuses on identifying and developing new therapeutics for age-related diseases in felines, deploying both computational and laboratory approaches.
Longevity.Technology: As people become more invested in extending their own health and longevity, they are also placing greater emphasis on doing the same for their pets, particularly cats. Cat owners are increasingly focused on boosting their feline companions’ well-being, aiming to extend both their health and lifespan. Advances in human longevity, such as early diagnostics, AI-powered disease detection, and innovative treatments for challenging conditions, are starting to influence cat health care, and cat longevity looks set to be big business; pet spending in the US alone is predicted to grow to $195.6 billion by 2030, and represents one of the largest consumer spending categories, with more than 66% of households in the US owning pets, including 46.5 million households in the US that own a cat [1].
According to data prepared for Longevity.Technology by digital marketing agency Antlerzz, there has been a 121% increase in online interest in cat longevity in the US over the last ten years; worldwide, there has been a similar trend, mirroring the growing interest in dog longevity.
“We support innovative, passionate entrepreneurs whose startups are improving the lives of pets, including through new treatments and longevity-oriented care,” said Garri Zmudze, co-founder of Ani.VC. “The Cat Health Company is one of those companies. Their work developing novel drugs for feline age-related diseases is poised to give cats and their owners many more quality years together.”
Dr Alex Voda, TCHT CEO and Cofounder said: “We are very grateful that AniVC is joining our mission. I’ve seen their team bring about amazing biotech and longevity companies over time, and their network in the veterinary space is incredible. Together, we’re looking forward to improving the lifespan and health of our companions.”
“Our startup is in a very good place in terms of support,” said Alex Bacita, COO and Cofounder, TCHC. “The pharma R&D expertise we have is amplified by the biotech and veterinary expertise that AniVC brings to our startup, and the computational expertise we have is solidified by the advice we receive from our mentors at Early Game VC. Thanks to the amazing angels, EGV and AniVC supporting us, we are confident that there is no limit to what we will be able accomplish.”
The Cat Health Company is already consolidating its position at the forefront of cat healthspan, having entered into a new partnership with EpiPaws to advance research on feline longevity earlier this year.
EpiPaws is funding a groundbreaking study that will collect omics data from a cohort of 100 cats, in collaboration with TCHC. This study aims to deepen the understanding of the genetic factors that influence feline aging, paving the way for the development of targeted therapies to extend the lifespan and healthspan of cats. With TCHC’s focus on creating novel drugs for age-related diseases and EpiPaws’ expertise in diagnostics and omics, this collaboration could pave a purrfect path towards transformative advancements to feline health.
Alex Voda told Longevity.Technology he is excited for the future. “As more people begin to look beyond their own longevity to that of their companions, we’re excited to lead the charge in redefining what’s possible for feline health,” he said. “With this new funding, we’re not just aiming to extend the lives of cats, we’re moving towards a future where nine healthy lives are only the beginning. Our goal is to create groundbreaking innovations that will give our pets more healthy, happy years alongside us.”
Stay tuned for our interview with Cat Health Company CEO and cofounder Alex Voda coming soon!
“Our startup is in a very good place in terms of support,” said Alex Bacita, COO and Cofounder, TCHC. “The pharma R&D expertise we have is amplified by the biotech and veterinary expertise that AniVC brings to our startup, and the computational expertise we have is solidified by the advice we receive from our mentors at Early Game VC. Thanks to the amazing angels, EGV and AniVC supporting us, we are confident that there is no limit to what we will be able accomplish.”
The Cat Health Company is already consolidating its position at the forefront of cat healthspan, having entered into a new partnership with EpiPaws to advance research on feline longevity earlier this year.
EpiPaws is funding a groundbreaking study that will collect omics data from a cohort of 100 cats, in collaboration with TCHC. This study aims to deepen the understanding of the genetic factors that influence feline aging, paving the way for the development of targeted therapies to extend the lifespan and healthspan of cats. With TCHC’s focus on creating novel drugs for age-related diseases and EpiPaws’ expertise in diagnostics and omics, this collaboration could pave a purrfect path towards transformative advancements to feline health.
Alex Voda told Longevity.Technology he is excited for the future. “As more people begin to look beyond their own longevity to that of their companions, we’re excited to lead the charge in redefining what’s possible for feline health,” he said. “With this new funding, we’re not just aiming to extend the lives of cats, we’re moving towards a future where nine healthy lives are only the beginning. Our goal is to create groundbreaking innovations that will give our pets more healthy, happy years alongside us.”
Stay tuned for our interview with Cat Health Company CEO and cofounder Alex Voda coming soon!
The Cat Health Company
DOG PPL
The first independent early-stage venture fund for the pet industry
Receive updates about ani.vc, our founders and our insights
hq@ani.vc
Ani.vc © 2024
Cookies policy
Privacy policy